LenioBio Secures EU Funding for Protein Medicine Production

LenioBio has been awarded €3.7 million from the EU4Health program to advance its ALiCE® protein expression system, aiming for cost-effective and rapid production of protein-based medicines.

LenioBio GmbH has been awarded €3.7 million from the EU4Health program to further develop its ALiCE® cell-free protein expression system, announced in a press release. The funding, provided by the European Health and Digital Executive Agency (HaDEA), will support the project until late 2027.

The initiative aims to enhance the ALiCE® platform for the rapid and cost-effective production of protein-based medicines, including vaccines and multispecific antibodies. Key objectives include scaling up lysate production, transitioning to continuous manufacturing, and establishing quality systems for GMP-grade production.

This project aligns with the European Union's strategic goals to improve the availability and affordability of essential medicines. By advancing innovative manufacturing processes, LenioBio seeks to provide a scalable and sustainable solution for the production of complex proteins.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Healthcare & Life Sciences AI

AI Brief (X)

More from: Funding

Waystar to Acquire Iodine Software for $1.25 Billion

Jul 24

Starseer Secures $2M to Enhance AI Security and Transparency

Jul 24

ArcSpan Secures $5.2 Million to Enhance AI Audience Tools

Jul 24

Aidoc Secures $150M to Advance Clinical AI Model CARE

Jul 23

AnyCreek Acquires Origin to Expand AI-Powered Outdoor Software

Jul 23

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.